Rivkin S - Search Results

1

High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.

Holmberg LA, Demirer T, Rowley S, Buckner CD, Goodman G, Maziarz R, Klarnet J, Zuckerman N, Harrer G, McCloskey R, Gersh R, Goldberg R, Nichols W, Jacobs A, Weiden P, Montgomery P, Rivkin S, Appelbaum FR, Bensinger WI. Holmberg LA, et al. Among authors: rivkin s. Bone Marrow Transplant. 1998 Oct;22(7):651-9. doi: 10.1038/sj.bmt.1701398. Bone Marrow Transplant. 1998. PMID: 9818692

2

High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer.

Gutierrez-Delgado F, Holmberg LA, Hooper H, Appelbaum FR, Livingston RB, Maziarz RT, Weiden P, Rivkin S, Montgomery P, Kawahara K, Bensinger W. Gutierrez-Delgado F, et al. Among authors: rivkin s. Bone Marrow Transplant. 2000 Jul;26(1):51-9. doi: 10.1038/sj.bmt.1702461. Bone Marrow Transplant. 2000. PMID: 10918405 Clinical Trial.

3

Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies.

Weaver CH, Bensinger WI, Appelbaum FR, Lilleby K, Sandmaier B, Brunvand M, Rowley S, Petersdorf S, Rivkin S, Gooley T, et al. Weaver CH, et al. Among authors: rivkin s. Bone Marrow Transplant. 1994 Nov;14(5):813-9. Bone Marrow Transplant. 1994. PMID: 7889015 Clinical Trial.

4

Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.

Schiffman KS, Bensinger WI, Appelbaum FR, Rowley S, Lilleby K, Clift RA, Weaver CH, Demirer T, Sanders JE, Petersdorf S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Maziarz R, Klarnet JP, Rivkin S, Trueblood K, Storb R, Holmberg L, Buckner CD. Schiffman KS, et al. Among authors: rivkin s. Bone Marrow Transplant. 1996 Jun;17(6):943-50. Bone Marrow Transplant. 1996. PMID: 8807098 Clinical Trial.

5

High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.

Bensinger WI, Schiffman KS, Holmberg L, Appelbaum FR, Maziarz R, Montgomery P, Ellis E, Rivkin S, Weiden P, Lilleby K, Rowley S, Petersdorf S, Klarnet JP, Nichols W, Hertler A, McCroskey R, Weaver CH, Buckner CD. Bensinger WI, et al. Among authors: rivkin s. Bone Marrow Transplant. 1997 Jun;19(12):1183-9. doi: 10.1038/sj.bmt.1700820. Bone Marrow Transplant. 1997. PMID: 9208111

6

Treatment of limited small-cell lung cancer with concurrent etoposide/cisplatin and radiotherapy followed by intensification with high-dose cyclophosphamide: a Southwest Oncology Group study.

Goodman GE, Crowley J, Livingston RB, Rivkin SE, Albain K, McCulloch JH. Goodman GE, et al. Among authors: rivkin se. J Clin Oncol. 1991 Mar;9(3):453-7. doi: 10.1200/JCO.1991.9.3.453. J Clin Oncol. 1991. PMID: 1847967 Clinical Trial.

7

Combined treatment with chemotherapy and neutron irradiation for limited non-small-cell lung cancer: a Southwest Oncology Group Study.

Livingston RB, Griffin BR, Higano CS, Laramore GE, Rivkin SE, Goldberg RS, Schulman SF. Livingston RB, et al. Among authors: rivkin se. J Clin Oncol. 1987 Nov;5(11):1716-24. doi: 10.1200/JCO.1987.5.11.1716. J Clin Oncol. 1987. PMID: 2824705 Clinical Trial.

8

Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer.

Livingston RB, Schulman S, Griffin BR, Tranum BL, Rivkin SE, Goldberg RS, Fabian CJ, Hammond N, Hynes H. Livingston RB, et al. Among authors: rivkin se. Cancer. 1987 Apr 1;59(7):1249-54. doi: 10.1002/1097-0142(19870401)59:7<1249::aid-cncr2820590703>3.0.co;2-k. Cancer. 1987. PMID: 3545430

9

Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group study.

Ellis GK, Green S, Schulman S, Coltman CA Jr, Hynes HE, Rivkin S, Livingston RB. Ellis GK, et al. Among authors: rivkin s. Cancer. 1991 Sep 1;68(5):934-9. doi: 10.1002/1097-0142(19910901)68:5<934::aid-cncr2820680504>3.0.co;2-n. Cancer. 1991. PMID: 1913489 Clinical Trial.

10

Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.

Rivkin SE, Green S, Metch B, Glucksberg H, Gad-el-Mawla N, Constanzi JJ, Hoogstraten B, Athens J, Maloney T, Osborne CK, et al. Rivkin SE, et al. J Clin Oncol. 1989 Sep;7(9):1229-38. doi: 10.1200/JCO.1989.7.9.1229. J Clin Oncol. 1989. PMID: 2671283 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters